Salubris Enters Drug Distribution Business With Shenzhen Acquisition
This article was originally published in PharmAsia News
Executive Summary
Salubris announced it acquired 100% equity of Shenzhen Jianshankang Pharmaceuticals for RMB 2 million, and would continue Jianshankang’s operations as a qualified pharmaceutical distributor.